Wellstar Experts Treat Head & Neck Cancer, STAT

Wellstar patients will be among the first in Georgia to benefit from a new, FDA-approved imaging technology that detects the extent of prostate cancer earlier and with greater accuracy than current imaging methods.

This diagnostic agent called PYLARIFY (piflufolastat F 18) is given to patients as an injection. Once it is in the body, it binds to PSMA, or Prostate Specific Membrane Antigens. Prostate cancer cells usually have a higher level of PSMA. 

When used with PET scans, this innovative technology gives physicians a clearer image of prostate cancer lesions and enables providers to determine the best course of treatment. 

“We have the most sensitive PET scan for prostate cancer available,” said Wellstar Radiation Oncologist Dr. Justin Hart.

Wellstar is among the first in Georgia to routinely offer PSMA PET scans with PYLARIFY.

While standard scans have limited sensitivity for prostate cancer, this advanced imaging is much more capable of identifying prostate cancer, which allows Wellstar doctors to determine if the cancer is limited to the prostate or if it has spread to other parts of the body.

“It allows us to make sure we’re not missing any sites of cancer that aren’t picked up with old-school imaging,” said Wellstar Urologist Dr. Justin Watson. “If there is an area of cancer outside what we’d typically treat and we pick it up with this imaging, we can make sure we address that area, too.”

Providers can then tailor treatment to each patient’s individual needs, collaborating with the patient to find the best course of action and improve outcomes.

“It’s actionable information to make sure patients get the right treatment. It makes all the difference in the world,” Dr. Hart said.

Dr. Hart and Dr. Watson compared the new imaging technology to upgrading a 20 inch tube style TV from 1981 to a 60 inch LCD flat screen TV today.

“This is several leaps forward in our ability to see prostate cancer on a scan in high resolution,” Dr. Watson said. “In the older scans, things are difficult to see and sometimes not even perceptible, and with the new scans, they light right up and we know much better what we’re dealing with.”

This PSMA imaging is currently available at Wellstar Kennestone Hospital, with plans to expand to other locations.

Men between the ages of 55 and 69 should discuss prostate cancer screening with their primary care providers, and men who are at higher risk may need to start screening earlier. Your Wellstar physician will get to know your health needs and history, then work with you to decide whether you might benefit from screenings.

If you have been diagnosed with prostate cancer, talk to your provider about whether PSMA imaging should be part of your care plan. To learn more about prostate cancer treatment at Wellstar, visit our prostate cancer page or call 1 (877) 366-6032.

From catching cancer to following through with expert care, Wellstar ensures patients never have to fight lung cancer alone.

Wellstar is dedicated to early intervention in lung cancer, which improves outcomes for patients. After detection of an abnormality on a CT scan, patients are immediately surrounded with an interdisciplinary support team devoted to their well-being.

Identifying lung cancer early

If you are at increased risk for developing lung cancer, talk to your provider about screenings. With a low-dose CT scan of the chest, it only takes a few seconds to check in on your lung health. These screenings are offered at most Wellstar imaging centers.

The United States Preventative Services Task Force recently revised lung screening guidelines. Patients may qualify for screening if they are 50 to 80 years old and smoked for 20 years. If they are a former smoker, they may qualify if they quit less than 15 years ago. The Center for Medicare & Medicaid Services is considering enacting these recommendations.

“Lung screening dramatically improves a person’s chances of detecting a lung cancer at an early stage and being cured of that cancer,” said Wellstar Thoracic Surgeon Dr. William Mayfield, who also serves as Wellstar’s Chief Surgical Officer.

Because finding cancer and starting treatment sooner can be life-saving, Wellstar has invested in the incidental nodule program. When people come into a hospital seeking care for something else — whether that be a health condition like appendicitis or a traumatic event like a motorcycle accident — they might get a scan of the abdomen or chest that also shows portions of the lungs.

Using artificial intelligence, reports of those scans are fed to report coordinators, categorized based on their risk level, and if the patient is higher-risk, forwarded to nurse navigators for review. Nurse navigators consult with physicians about the findings, and Wellstar can then initiate care if cancer is found.

“People that come to the hospital for other problems may also be walking around with a lung cancer they didn’t know about,” Dr. Mayfield said.

The program, which started in fall 2020, has already identified 28 cases of lung cancer.

“Now those people are getting care, and it’s quite likely those cancers would have been missed,” Dr. Mayfield said.

Wellstar is developing another incidental nodule program for the abdominal area, which could lead to the discovery of several cancers including ovarian, kidney, bladder and liver cancers.

The program aligns with Wellstar’s goals of enhancing the health and well-being of everyone we serve.

“It was the right thing to do for the community. If we miss these cancers, it is a broken promise to the patient,” Dr. Mayfield said.

Then, if cancer is found, Wellstar “closes the loop” by initiating treatment and connecting the patient with resources, Dr. Mayfield said.

Expert care and support at every step

From the very beginning, Wellstar’s lung cancer patients are surrounded by a team of experts. Rather than go through the time-consuming process of driving to multiple appointments with different specialists, patients meet with all these providers in one place.

The Wellstar Lung Cancer STAT Clinic gives patients immediate access to specialists in medical oncology, radiation oncology, pulmonary medicine and thoracic surgery.

“No other health system does multidisciplinary care the way Wellstar does,” Dr. Mayfield said.

Getting multiple expert opinions from the start not only gives patients peace of mind, it speeds up treatment, too. In the United States, the average time between an abnormal scan and the beginning of treatment is 95 days, Dr. Mayfield said. The STAT Clinic reduces that time to as little as 14 days. Time-to-treatment affects long-term survival in lung cancer patients, Dr. Mayfield said — a six-week delay can reduce five-year survival by up to 13%, according to research from the Cleveland Clinic.

“Time really does matter in the treatment and diagnosis of lung cancer,” Dr. Mayfield said.

High-tech surgery options

For many patients, surgery is a crucial part of lung cancer treatment. Wellstar offers several minimally-invasive options, reducing recovery time for patients.

Dr. Mayfield said more than 90% of Wellstar’s lung cancer surgeries are performed using either the da Vinci Surgical System or Video Assisted Thoracic Surgery techniques (VATS).

Minimally-invasive surgeries reduce pain, scarring, blood loss and infection, as well as time to recover — getting patients back to work and other routines quicker.

The da Vinci system is equipped with 3D cameras and instruments that can make very intricate, precise movements, allowing for shorter incisions and more accurate surgery. Some patients can leave the hospital as early as the next day.

To prevent lung cancer and keep your lungs healthy, talk to your primary care provider and follow a few tips, such as avoiding smoking and getting your exercise. Learn more about treatments on our cancer care page.

Patients in West Georgia don’t need to drive to Atlanta for life-saving cancer care. The Enoch Callaway Cancer Center keeps quality care close to home and combines the resources of a large facility with the personalized, compassionate feel of a smaller location.

“One of my missions is to bring great cancer care to people close to where they live, so they can access that care much more easily,” said Wellstar Radiation Oncologist Dr. Robert Taylor. “To have Wellstar backing this world-class treatment, building this new cancer center and this fantastic team that we have, is absolutely stellar.”

At the Enoch Callaway Cancer Center at Wellstar West Georgia Medical Center, patients will find the latest in technology and clinical trials, paired with expert providers who care for both their physical and mental well-being.

Eliminating tumors virtually

Cutting-edge technology at the Cancer Center allows providers to target tumors using X-ray technology, keeping the journey to living cancer-free painless for patients.

Stereotactic ablative radiotherapy takes about 30 minutes per treatment, with some patients requiring multiple treatments and others only needing one. It is most effective in early stage brain or lung cancer and can also be used to treat metastatic cancer.

“We’re able to use X-rays to very precisely target a tumor and literally kill that tumor inside there without the patient undergoing any surgery,” Dr. Taylor said. “Despite the name, there’s no cutting involved, and there’s no anesthesia involved.”

The patient lies on a table for the treatment, and “at the end of that 30 minutes, they will get up off that treatment table and walk out of the facility feeling the same as they did when they came in,” Dr. Taylor said.

“It’s absolutely miraculous to see people get off the table and know their brain tumor has been cured or their lung cancer has been cured,” Dr. Taylor said.